ISIS PHARMACEUTICALS INC DEL's ticker is and the CUSIP is 464337AJ3. A total of 54 filers reported holding ISIS PHARMACEUTICALS INC DEL in Q4 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2021 | $2,000 | 0.0% | 2,000 | 0.0% | 0.00% | – |
Q1 2021 | $2,000 | -100.0% | 2,000 | -100.0% | 0.00% | -100.0% |
Q3 2020 | $8,064,000 | +2.3% | 7,777,000 | +8.6% | 0.18% | -3.8% |
Q2 2020 | $7,883,000 | +48.7% | 7,159,000 | +35.5% | 0.18% | +60.9% |
Q1 2020 | $5,301,000 | +1643.8% | 5,283,000 | +1893.6% | 0.12% | +1816.7% |
Q4 2019 | $304,000 | -98.5% | 265,000 | -98.5% | 0.01% | -98.4% |
Q3 2019 | $20,261,000 | +58.9% | 17,756,000 | +65.2% | 0.38% | +53.8% |
Q2 2019 | $12,751,000 | -25.4% | 10,746,000 | -15.0% | 0.25% | -34.5% |
Q1 2019 | $17,103,000 | -63.9% | 12,649,000 | -71.3% | 0.38% | -67.1% |
Q4 2018 | $47,388,000 | -36.9% | 44,032,000 | -38.2% | 1.15% | -25.9% |
Q3 2018 | $75,071,000 | +13.4% | 71,231,000 | +5.6% | 1.55% | +11.1% |
Q2 2018 | $66,181,000 | +37.3% | 67,450,000 | +38.8% | 1.39% | +47.1% |
Q1 2018 | $48,198,000 | +59.8% | 48,598,000 | +70.3% | 0.95% | +63.7% |
Q4 2017 | $30,156,000 | -25.2% | 28,544,000 | -24.9% | 0.58% | -24.3% |
Q3 2017 | $40,330,000 | -6.0% | 38,030,000 | -5.7% | 0.76% | -6.9% |
Q2 2017 | $42,924,000 | -37.9% | 40,312,000 | -43.7% | 0.82% | -36.5% |
Q1 2017 | $69,095,000 | +5.5% | 71,584,000 | +10.9% | 1.29% | +7.3% |
Q4 2016 | $65,482,000 | -1.2% | 64,541,000 | -9.1% | 1.20% | +25.8% |
Q3 2016 | $66,281,000 | +31.7% | 70,972,000 | +0.2% | 0.96% | +22.8% |
Q2 2016 | $50,346,000 | -32.5% | 70,827,000 | -13.2% | 0.78% | -31.5% |
Q1 2016 | $74,545,000 | +24.5% | 81,578,000 | +52.0% | 1.14% | +23.4% |
Q4 2015 | $59,882,000 | – | 53,683,000 | – | 0.92% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|